Skip to main content
ACH
NYSE Trade & Services

Accendra Health Announces $1.5B Debt Optimization, Reduces Funded Debt by $371M, Extends Maturities

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Positive
Importance info
9
Price
$3.58
Mkt Cap
$273.648M
52W Low
$1.84
52W High
$9.55
52W Position info
95% above low
Off High info
63% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

ACH sits 95% above its 52-week low of $1.84.

Summary

Accendra Health announced a comprehensive $1.5 billion balance sheet optimization, reducing funded debt by $371 million and extending debt maturities, which is critical for its financial stability. The company also reported mixed Q1 2026 financial results, with a GAAP EPS beat but declining revenue and adjusted EBITDA.


Key Events · Financing and Capital Events · ACH

  • Comprehensive Balance Sheet Optimization

    Accendra Health announced a more than $1.5 billion balance sheet optimization transaction with commitments from existing creditors, aimed at strengthening the balance sheet and reducing leverage.

  • Significant Debt Reduction

    The transaction is expected to reduce total funded debt by up to $371 million, including discount capture and cash, from $2.123 billion to an illustrative pro forma of $1.752 billion.

  • Extended Debt Maturities

    The weighted average life of the company's debt will roughly double from approximately 2.7 years to 5.5 years, addressing near-term maturities and enhancing liquidity runway.

  • Mixed Q1 2026 Financial Results

    The company reported a GAAP loss per share of $(0.08), which was better than analyst expectations of $(0.10). However, net revenue declined to $627.8 million from $673.9 million year-over-year, and Adjusted EBITDA decreased to $58.4 million from $96.0 million.


Analysis · ACH · Trade & Services

This filing details a critical balance sheet optimization that significantly de-risks Accendra Health's financial position. Given the company's previously reported negative shareholder equity and substantial net loss in 2025, securing commitments for a $1.5 billion transaction that reduces funded debt by $371 million and extends maturities is a major positive development. It provides essential liquidity and financial flexibility, addressing immediate solvency concerns and establishing a more stable long-term capital structure. While Q1 results were mixed, the successful debt restructuring is the dominant and market-moving aspect of this announcement.

At the time of this filing, ACH was trading at $3.58 on NYSE in the Trade & Services sector, with a market capitalization of approximately $273.6M. The 52-week trading range was $1.84 to $9.55. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ACH - Latest Insights

ACH
Jun 25, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.17
Real-time Price: $2.92 info
Change: -$0.250 (-8%) info
Market Cap: $223.624M info
ACH
Jun 15, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $3.03
Real-time Price: $2.92 info
Change: -$0.110 (-4%) info
Market Cap: $223.624M info
ACH
Jun 15, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.03
Real-time Price: $2.92 info
Change: -$0.110 (-4%) info
Market Cap: $223.624M info
ACH
May 22, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.83
Real-time Price: $2.92 info
Change: +$0.090 (+3%) info
Market Cap: $223.624M info
ACH
May 11, 2026, 11:59 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.96
Real-time Price: $2.92 info
Change: -$1.04 (-26%) info
Market Cap: $223.624M info